Blog

Company News

Industry Trends

Laws Regulations

All Categories >

27

2023-03

The EBC Expo is a showcase for the bioindustry.

Yesterday, I attended the 2023 Yimao Biotechnology Industry Conference and Exhibition together with my colleagues. On the first day of the event, my observations in Hall C—primarily dedicated to instruments, equipment, and consumables—revealed the following: the upstream segment was dominated by fermentation tanks and bioreactors, while the downstream segment featured purification equipment such as chromatography columns, liquid-handling chromatography systems, and ATF tangential-flow filtration systems. General laboratory equipment included temperature-controlled instruments, liquid-handling workstations, ultrapure water systems, and pipette-assembly/sealing machines. As for reagents and consumables, the main categories were culture media, packing materials, filters, and culture flasks. Notably, most of the custom-designed booths were occupied by domestic brands, whereas several well-known foreign brands—such as Sartorius and Thermo Fisher—did not have any exhibition space at all. In contrast, leading Chinese instrument and equipment companies had all set up prominently designed, custom-built booths, including JinYi Shengshi, Biolab, Saiqiao Bio, Zhongboruikang, and Hanbang Tech.

2023-03-27

He Yousheng

22

2023-03

ChemoMetec Fully Automated Cell Counter | More Accurate Counts, Higher Standards!

The cell therapy and gene therapy industries are experiencing rapid growth, and to ensure the quality of their final products, every process and step relies on precise cell counting. ChemoMetec, a Danish company, is a global leader in the manufacture of cell-counting and analysis equipment, specializing in the development and production of high-precision instruments that deliver accurate data to thousands of customers across the biotechnology, pharmaceutical, and academic sectors. Its NucleoCounter® series—comprising the NC-200™, NC-250™, and NC-3000™ models—employs advanced cell-image analysis and fluorescence staining technologies to determine cell count and viability, thereby providing maximum assurance of precision, stability, and consistency in cell-counting processes. The company is currently successfully listed on the NASDAQ.

2023-03-22

He Yousheng

14

2023-03

Good News | We are delighted to announce that Hycells has officially become a service agent for Suzhou Yudeyang Biotechnology Co., Ltd.!

Suzhou Yudeyang Biotechnology Co., Ltd., established in January 2020, is a company dedicated to providing biosafety testing services for the biopharmaceutical industry. The company has now built a comprehensive platform for MCB/WCB/EOPC/UPB cell bank testing and virus clearance validation, equipped with GMP and GLP quality systems that comply with both Chinese and U.S. regulatory requirements. With proven experience in successfully submitting regulatory applications in both China and the United States, Yudeyang is fully capable of meeting the IND and BLA regulatory submission requirements of biopharmaceutical clients. In China, aside from WuXi AppTec Testing in Suzhou, which offers end-to-end biosafety testing that satisfies dual-regulatory submission requirements, Yudeyang is the second testing platform able to meet these regulatory standards.

2023-03-14

He Yousheng

07

2023-03

Hycells Goddess Festival | Paying Tribute to “Her” Power

In the vibrant month of March, as International Women’s Day approaches, Hycells Biotechnology has specially curated a “Women’s Day” celebration to extend our heartfelt wishes and sincere gratitude to every female colleague at the company. We have prepared exclusive gifts just for you, along with a half-day off, so that you can savor little moments of joy and fulfillment amidst your busy work and daily life.

2023-03-07

He Yousheng

02

2023-03

Shenzhen Introduces the Nation’s First Special Legislation on the Cell and Gene Industry

On January 6, 2023, the Standing Committee of the Shenzhen Municipal People’s Congress announced that the nation’s first specialized legislation on the cell and gene industry—the Regulations of the Shenzhen Special Economic Zone on Promoting the Cell and Gene Industry (hereinafter referred to as the “Regulations”)—has been adopted by vote and will come into effect on March 1.

2023-03-02

He Yousheng

02

2023-03

Rising to the Challenge in 2023: Full-Throttle Momentum | Hycells’s 2023 Spring Festival Gala Was a Resounding Success!

With the arrival of spring, all things come back to life. On February 24, despite their busy schedules, all colleagues at Hycells headed to an Anji resort to kick off the company’s three-day, two-night Spring Annual Gathering for 2023.

2023-03-02

He Yousheng
< 1...192021...24 >